Immunome
IMNM
IMNM
180 hedge funds and large institutions have $2.54B invested in Immunome in 2025 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 76 increasing their positions, 36 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
23.99% more ownership
Funds ownership: 104.99% → 128.98% (+24%)
18% more funds holding
Funds holding: 153 → 180 (+27)
57% less call options, than puts
Call options by funds: $22.2M | Put options by funds: $51.7M
Holders
180
Holding in Top 10
5
Calls
$22.2M
Puts
$51.7M
Top Buyers
| 1 | +$87.8M | |
| 2 | +$61.3M | |
| 3 | +$52.8M | |
| 4 |
JP Morgan Chase
New York
|
+$49.5M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$38.8M |
Top Sellers
| 1 | -$37.3M | |
| 2 | -$21.5M | |
| 3 | -$18.2M | |
| 4 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$12.1M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$6.36M |
